Stiff-legged Pharmaceutical businesses vs. adapt and survive
It interesting how industries that grows becomes stiff-legged. The Pharmaceutical businesses will not survive according to specialist if they don’t adapt to the market. The reason for why they have become so stiff is because they could (no competition – lobbying that their Titanic pills are good for al consumers). But now when the market grows (partly as an result of their products…). They have to learn how to tap into consumer focus and learn what customization means.
The reason for why they want to learn this is more money on a growing market. Also that more and more government are changing/updating the legal system so greed doesn’t kill patients.
Simon Friend, global pharmaceutical leader, PricewaterhouseCoopers did hold a lecture at KTH in Stockholm. The point of the lecture is found here at Mentoronline.se (in Swedish).
Global Pharma Market Predicted to More Than Double In Value to $1.3 Trillion by 2020: Industry Must Transform to Capitalise On Opportunities. Pwc.com
If The Pharmaceutical businesses don’t listen they will end up with more movies as Sicko (and as Simon did say having image problems so they don’t can employ the best science workers). Simon also points out in his lecture that it’s strange that a business that purpose is to save live is not trusted.
Related post on this blog:
Killing costumer is good business for lawyer.
Profit kills patient in Sicko.
Are you playing in the Titanic band?